Inhaler/Nasal
BREZTRI AEROSPHERE PRESSURISED INHALATION, SUSPENSION 160/7.2/5MCG/INHALATION
Summary
BREZTRI AEROSPHERE PRESSURISED INHALATION, SUSPENSION 160/7.2/5MCG/INHALATION — Inhaler/Nasal containing budesonide, formoterol fumarate, glycopyrronium (as bromide). Hong Kong Registration No. HK-67728. Certificate Holder: ASTRAZENECA HONG KONG LIMITED. Date of Registration: 08 Feb, 2023.
Product NameBREZTRI AEROSPHERE PRESSURISED INHALATION, SUSPENSION 160/7.2/5MCG/INHALATION
Registration No.HK-67728
Certificate HolderASTRAZENECA HONG KONG LIMITED
Holder AddressUNIT 1-3, 11/F, CHINA TAIPING FINANCE CENTRE, 18 KING WAH RD, NORTH POINT, HONG KONG
Ingredientsbudesonide, formoterol fumarate, glycopyrronium (as bromide)
Dosage FormInhaler/Nasal
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration08 Feb, 2023
ATC codesA07EA06, D07AC09, D11AA01, R01AD05, R03AC13, R03BA02, R03CC15
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism / D Dermatologicals / R Respiratory System
All ATC groupsA07, D07, D11, R01, R03
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。